{"DataElement":{"publicId":"62719","version":"3","preferredName":"Superficial Bladder Malignant Neoplasm Increase T Stage Progression Category","preferredDefinition":"a numeric value for tumor involvement in TNM staging to indicate the most advanced severity of infiltrating carcinoma that has invaded into muscularis propia of the urinary bladder wall.","longName":"SBL_MLN_IN_T_PRO_CAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2010331","version":"3","preferredName":"Superficial Bladder Malignant Neoplasm Increase T Stage Progression","preferredDefinition":"related to advancing severity of infiltrating carcinoma that had not invaded muscularis propia of the urinary bladder wall to produce a larger numeric value for tumor involvement in TNM staging.","longName":"SU_BL_MALN_IN_T_PROG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2495260","version":"1","preferredName":"Superficial Bladder Cancer Malignant Neoplasm","preferredDefinition":"Superficial Bladder Cancer is a term used by urologists to describe infiltrating carcinomas that have not invaded into the muscularis propia of the urinary bladder wall regardless of their histologic type or grade, and therefore it does not represent a pathologic entity.  It is important for the term stage 0is bladder cancer (carcinoma in situ of the bladder) not to be equated with superficial bladder cancer.  Stage I bladder cancer may be considered superficial. --2003:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C27474:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Muscle Invasive Bladder Carcinoma","conceptCode":"C27474","definition":"An infiltrating carcinoma of the bladder that has not invaded into the bladder muscularis propria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"187D4A5D-CFB1-6372-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"ONEDATA","dateModified":"2006-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2495262","version":"1","preferredName":"Increase T Stage Progression","preferredDefinition":"Increase; a process of becoming larger or more numerous or more important.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:Progression; advancement in extent or severity.","longName":"C25533:C25728:C25331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Increase","conceptCode":"C25533","definition":"A process of becoming larger, more numerous, more important, or more likely.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progression","conceptCode":"C25331","definition":"Progression; advancement in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"187CF30D-A194-03FF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"ONEDATA","dateModified":"2006-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"187BF8DF-7468-59D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015398","version":"3","preferredName":"Superficial Bladder Malignant Neoplasm Increase T Stage Progression Category","preferredDefinition":"a numeric value for tumor involvement in TNM staging to indicate the most advanced severity of infiltrating carcinoma that has invaded into muscularis propia of the urinary bladder wall.","longName":"SBL_MLN_IN_T_PRO_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T2","valueDescription":"T2","ValueMeaning":{"publicId":"2560156","version":"1","preferredName":"T2","longName":"2560156v1.00","preferredDefinition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B809-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E563-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"ONEDATA","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"T3","valueDescription":"T3","ValueMeaning":{"publicId":"2560165","version":"1","preferredName":"T3","longName":"2560165v1.00","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T3 TNM Finding","conceptCode":"C48728","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B812-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E56D-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"ONEDATA","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"T4","valueDescription":"T4","ValueMeaning":{"publicId":"2560174","version":"1","preferredName":"T4","longName":"2560174v1.00","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B81B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E577-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"ONEDATA","dateModified":"2006-07-13","deletedIndicator":"No"},{"value":"Tx","valueDescription":"T STAGE OF TUMOR CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2560135","version":"1","preferredName":"T STAGE OF TUMOR CANNOT BE ASSESSED","longName":"2560135","preferredDefinition":"T STAGE OF TUMOR CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"187BDFDB-E581-56C7-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"ONEDATA","dateModified":"2006-07-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184279","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"Category","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1A66-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"187BDFDB-E54F-56C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000312","version":"1","longName":"Superficial Bladder","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Highest T Category of Diagnos","type":"Preferred Question Text","description":"Highest T Category of Diagnosed Tumor >T1","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Progression T Category Increase","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"187BCC73-E3C3-54AB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-13","modifiedBy":"REEVESD","dateModified":"2011-04-05","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}